Table 2.
Open in new tab

Susceptibility testing resulting for adherent (biofilm) strains.

StrainsaDaptomycinMBEC (mg L−1)MoxifloxacinMBEC (mg L−1)
MBEC (mg L−1)daptomycin + pAcDEDbMBEC (mg L−1)moxifloxacin + pAcDEDb
ATCC25923 (MSSA)128326464
Surv375 (MSSA)102432256128
Surv651 (MRSA)10243210241024
Surv456 (MRSA)102432256512
Surv999 (MRSA)512325121024
SurvS027 (MSSA)128326464
Surv179 (MRSA)102432256128
StrainsaDaptomycinMBEC (mg L−1)MoxifloxacinMBEC (mg L−1)
MBEC (mg L−1)daptomycin + pAcDEDbMBEC (mg L−1)moxifloxacin + pAcDEDb
ATCC25923 (MSSA)128326464
Surv375 (MSSA)102432256128
Surv651 (MRSA)10243210241024
Surv456 (MRSA)102432256512
Surv999 (MRSA)512325121024
SurvS027 (MSSA)128326464
Surv179 (MRSA)102432256128
a

All clinical isolates belong to the epidemic CC5 or CC8 clonal complexes.

b

32 mg L−1 pAcDED was used for combinations.

Table 2.
Open in new tab

Susceptibility testing resulting for adherent (biofilm) strains.

StrainsaDaptomycinMBEC (mg L−1)MoxifloxacinMBEC (mg L−1)
MBEC (mg L−1)daptomycin + pAcDEDbMBEC (mg L−1)moxifloxacin + pAcDEDb
ATCC25923 (MSSA)128326464
Surv375 (MSSA)102432256128
Surv651 (MRSA)10243210241024
Surv456 (MRSA)102432256512
Surv999 (MRSA)512325121024
SurvS027 (MSSA)128326464
Surv179 (MRSA)102432256128
StrainsaDaptomycinMBEC (mg L−1)MoxifloxacinMBEC (mg L−1)
MBEC (mg L−1)daptomycin + pAcDEDbMBEC (mg L−1)moxifloxacin + pAcDEDb
ATCC25923 (MSSA)128326464
Surv375 (MSSA)102432256128
Surv651 (MRSA)10243210241024
Surv456 (MRSA)102432256512
Surv999 (MRSA)512325121024
SurvS027 (MSSA)128326464
Surv179 (MRSA)102432256128
a

All clinical isolates belong to the epidemic CC5 or CC8 clonal complexes.

b

32 mg L−1 pAcDED was used for combinations.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close